JOURNAL OF NEUROTRAUMA, 2009 · DOI: 10.1089=neu.2007.0464 · Published: January 1, 2009
The study investigates how ibuprofen, a common anti-inflammatory drug, can aid recovery after spinal cord injury. It focuses on ibuprofen's ability to reduce RhoA activity, a protein that inhibits axonal regeneration. Researchers found that ibuprofen reduces RhoA signaling and myelin-induced inhibition of neurite outgrowth in lab experiments. Furthermore, rats treated with ibuprofen after spinal cord injury showed improved walking ability. The benefits of ibuprofen appear to stem from protecting spinal cord tissue, stimulating the growth of new nerve connections, and enabling some nerve regeneration. This suggests ibuprofen has potential as a therapy for spinal cord injuries.
Ibuprofen and related Rho-inhibiting compounds have therapeutic potential for spinal cord injury.
Ibuprofen administration may only be necessary in the subacute period, further avoiding the risks of chronic administration.
Compounds related to ibuprofen might provide a useful starting point to screen for optimal Rho pathway inhibition and future SCI or stroke recovery therapeutics.